Synergistic Antitumor Effects of Berbamine and Paclitaxel through ROS/Akt Pathway in Glioma Cells.

about

Synergistic Antitumor Effects of Berbamine and Paclitaxel through ROS/Akt Pathway in Glioma Cells.

Item

http://www.wikidata.org/entity/Q41524387

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Synergistic Antitumor Effects ...... S/Akt Pathway in Glioma Cells.

@en

type

Item

label

Synergistic Antitumor Effects ...... S/Akt Pathway in Glioma Cells.

@en

prefLabel

Synergistic Antitumor Effects ...... S/Akt Pathway in Glioma Cells.

@en

P1476

Synergistic Antitumor Effects ...... OS/Akt Pathway in Glioma Cells

@en

P2093

Linshan Fu

http://www.w3.org/2001/XMLSchema#string

P2860

A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.

Dual blockade of phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancer.

Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis.

The efficacy and toxicity of paclitaxel plus S-1 compared with paclitaxel plus 5-FU for advanced gastric cancer: a PRISMA systematic review and meta-analysis of randomized controlled trials.

Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.

Prognostic awareness and communication of prognostic information in malignant glioma: a systematic review.

A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling.

P304

8152526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/8152526

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Feng Jia

Shu Ruan

Ning Liu

P577

2017-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28883885

http://www.w3.org/2001/XMLSchema#string

P932

5572090

http://www.w3.org/2001/XMLSchema#string

Synergistic Antitumor Effects of Berbamine and Paclitaxel through ROS/Akt Pathway in Glioma Cells.

about

Synergistic Antitumor Effects of Berbamine and Paclitaxel through ROS/Akt Pathway in Glioma Cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932